Recent studies have found an increase in SOCS3 expression in the hepatocytes of patients with NAFLD, which may be related to inflammation and insulin resistance in these conditions (Zhang et al., 2021). This evidence concerns the gene SOCS3 and metabolic dysfunction-associated steatotic liver disease.